XML 184 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies (Details)
1 Months Ended 6 Months Ended 12 Months Ended
Jan. 19, 2024
USD ($)
shares
May 30, 2023
USD ($)
Jan. 31, 2021
USD ($)
Nov. 30, 2020
USD ($)
Jan. 01, 2016
USD ($)
Jan. 01, 2016
EUR (€)
Mar. 31, 2015
USD ($)
Mar. 31, 2015
EUR (€)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Commitments and Contingencies [Line Items]                        
Cumulative total payments         $ 2,142,920 € 2,000,000 $ 16,013,000 € 15,000,000        
Net sales revenue percentage         1.00% 1.00% 3.00% 3.00%        
Sublicensing revenue         2.00% 2.00% 10.00% 10.00%        
Milestone payment percentage       10.00% 2.00% 2.00% 25.00% 25.00%        
Royalty payment             1.00% 1.00%        
Revenue received             $ 100,000,000          
Issuance of promissory note             1,400,000   $ 1,211,463   $ 1,211,463 $ 1,211,463
Payment of other asset       $ 50,000                
Royalty, percentage       1.50%                
Commercial sales       $ 2,000,000                
Received of upfront payments       $ 2,000,000                
License agreement terms       11 years                
Payable amount       $ 2,000,000                
Payment of note payable     $ 50,000                  
Consulting fee $ 320,000 $ 480,000                 160,000  
Issuance of value                 $ (405,753) $ (208,686) $ (1,055,985)  
Rent expense                       $ 8,000
Previously Reported [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments         $ 2,135,000              
Consulting Agreement [Member]                        
Commitments and Contingencies [Line Items]                        
Issuance of shares (in Shares) | shares 14,558,285                      
Maximum [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments         3,214,380 € 3,000,000 16,071,900          
Maximum [Member] | Previously Reported [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments         $ 3,203,000   8,540,000          
Minimum [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments             8,571,680 € 8,000,000        
Common Shares [Member]                        
Commitments and Contingencies [Line Items]                        
Issuance of value $ 3,202,823                      
Common Shares [Member] | Consulting Agreement [Member]                        
Commitments and Contingencies [Line Items]                        
Issuance of shares (in Shares) | shares 14,558,285                      
Galantos Pharma GmbH [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments             10,714,600 € 10,000,000        
Galantos Pharma GmbH [Member] | Previously Reported [Member]                        
Commitments and Contingencies [Line Items]                        
Cumulative total payments             $ 10,675,000